Antion Biosciences SA

The advanced therapies industry in the UK and elsewhere is facing a shortage of skilled employees when it comes to the areas of manufacturing, quality and R&D, however there are some solutions, heard

Big pharma companies are on the hunt for RNA-focused drug discovery and development technologies, not just to bring new drug candidates into their research and development pipelines but to build in-ho

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. The January J.P. Morgan Healthcare Conf